Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes

References

• Casper RF, Yen SS. Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol 1985;22:293–312
   PubMed Web of Science ®Google Scholar
• De Leo V, Morgante G, Musacchio MC, Faldini E, Delia A, Petraglia F. The safety of veralipride. Expert Opin Drug Saf 2006;5:695–701
   PubMed Web of Science ®Google Scholar
• Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes D. Hot flushes. Lancet 2002;360:1851–1861
   PubMed Web of Science ®Google Scholar
• Verbeke K, Dhont M, Vandekerckhove D. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women. Maturitas 1988;10:225–230
   PubMed Web of Science ®Google Scholar
• Berendsen HH. The role of serotonin in hot flushes. Maturitas 2000;36:155–164
   PubMed Web of Science ®Google Scholar
• Stearns V. Clinical update: new treatments for hot flushes. Lancet 2007;369:2062–2064
   PubMed Web of Science ®Google Scholar
• Gal EM. Tryptophan-5-hydroxylase: function and control. Adv Biochem Psychopharmacol 1974;11:1–11
   PubMedGoogle Scholar
• Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004;305:217–219
   PubMed Web of Science ®Google Scholar
• Carretti N, Florio P, Reis FM, Comai S, Petraglia F, Costa CV. Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol. Climacteric 2007;10:393–399
   PubMed Web of Science ®Google Scholar
• Eltayb A, Lindblom S, Oerther S, Ahlenius S. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat. Acta Physiol Scand 2001;172:205–209
   PubMedGoogle Scholar
• Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103–115
   PubMed Web of Science ®Google Scholar
• Carretti N, Florio P, Bertolin A, Costa CV, Allegri G, Zilli G. Serum fluctuations of total and free tryptophan levels during the menstrual cycle are related to gonadotrophins and reflect brain serotonin utilization. Hum Reprod 2005;20:1548–1553
   PubMed Web of Science ®Google Scholar
• De Antoni A, Allegri G, Costa C, Vanzan S, Bertolin A, Carretti N. Total and free tryptophan levels in serum of newborn infants. Relationship with serotonin and nicotinic acid pathway. Acta Vitaminol Enzimol 1980;2:17–20
   PubMedGoogle Scholar
• McMenamy RH, Oncley JL. The specific binding of tryptophan to serum albumin. J Biol Chem 1985;233:1436–1447
   Google Scholar
• Costa C, Bettero A, Allegri G. Rapid measurement of tryptophan, 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in human CSF by selective fluorescence and HPLC. Giorn It Chim Clin 1987;12:307–312
   Google Scholar
• Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145:869–879
   PubMed Web of Science ®Google Scholar
• Maki PM, Drogos LL, Rubin LH, Banuvar S, Shulman LP, Geller SE. Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 2008;15:848–856
   PubMed Web of Science ®Google Scholar
• Horiuchi J, McDowall LM, Dampney RA. Differential control of cardiac and sympathetic vasomotor activity from the dorsomedial hypothalamus. Clin Exp Pharmacol Physiol 2006;33:1265–1268
   Google Scholar
• Ramage AG. Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res Bull 2001;56:425–439
   PubMed Web of Science ®Google Scholar
• Tolins JP, Shultz PJ, Raij L. Role of endothelium-derived relaxing factor in regulation of vascular tone and remodeling. Update on humoral regulation of vascular tone. Hypertension 1991;17:909–916
   PubMed Web of Science ®Google Scholar
• Gonzales GF, Carillo C. Blood serotonin levels in postmenopausal women: effects of age and serum estradiol levels. Maturitas 1993;17:23–29
   PubMed Web of Science ®Google Scholar
• Blum I, Vered Y, Lifshitz A, et al The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Isr J Med Sci 1996;32:1158–1162
   PubMedGoogle Scholar
• Halbreich U, Rojanski N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995;37:434–441
   PubMed Web of Science ®Google Scholar
• Rubinow DR, Schmidt PJ. Gonadal steroid regulation of mood: the lessons of premenstrual syndrome. Front Neuroendocrinol 2006;27:210–216
   PubMed Web of Science ®Google Scholar
• Bethea CL, Mirkes SJ, Shively CA, Adams MR. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry 2000;47:562–576
   PubMed Web of Science ®Google Scholar
• Lippert TH, Filshie M, Mueck AO, Seeger H, Zwirner M. Urinary 5-hydroxyindole acetic acid excretion after estradiol treatment of menopausal women. Maturitas 1996;24:37–41
   PubMed Web of Science ®Google Scholar
• Melis GB, Cagnacci A, Gambacciani M, Paoletti AM, Moggi L, Fioretti P. Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride. J Clin Endocrinol Metab 1988;66:964–967
   PubMed Web of Science ®Google Scholar